Skip to main content
Autobound logo

Novartis news and events in 2026

Novartis news, hiring, layoffs, acquisitions, executive changes and Reddit, Glassdoor, podcast and web signals in one place. Every row is dated and links to its source.

PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn

Dated updates
78
Last event
Sep 29, 2026
Open rolesSnapshot Sep 29, 2026
337

Overview

Novartis by topic

Latest events

Latest Novartis events

All Novartis news →
  1. Revenue
    3 steps for taking on Novartis in radiopharma: Curium up firstNovartis generated $1.7 billion in revenue from its radioligand therapies Lutathera and Pluvicto in the first half of the year.
    biospace.com
  2. In development
    Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)Novartis's drug Cosentyx® (secukinumab) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), recommending it for marketing authorization to treat polymyalgia rheumatica (PMR).
    globenewswire.com
  3. News
    Novartis to pay $125M for blood-brain barrier crossing platform$125M · With Sironax
    biopharmadive.com
  4. Investment
    Novartis strengthens Tyrol as a business location with new investments in KufsteinNovartis has invested approximately 1.8 billion Euro in Austria over the past ten years, strengthening its sites in Kundl and Schaftenau.
    weltstimme.com
  5. Asset sale
    Novartis India Receives Detailed Public Statement for ₹552.49 Crore Open OfferNovartis AG has agreed to sell its 70.68% stake in Novartis India Limited to a consortium led by WaveRise Investments Limited for a total consideration of ₹1,445.89 crore.
    scanx.trade
  6. In development
    Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1)Novartis is planning to meet with the FDA to discuss next steps for its delpacibart braxlosiran (del-brax) therapy for facioscapulohumeral muscular dystrophy (FSHD).
    globenewswire.com
  7. Office expansion
    Novartis continues to cut jobs in SwitzerlandNovartis plans to move part of its biologics production activities from Kleinbasel to its campus in Basel by the end of 2027.
    syna.ch
  8. Asset sale
    Innexis Acquires Novartis's Kundl SiteWith Innexis Group
    chemanager-online.com
  9. Layoff
    Novartis cuts 130 jobs in Basel: Biologics production in Kleinbasel to be abandoned130 roles (reported)
    bazonline.ch
  10. Facility expansion
    Novartis: towards a reduction of 130 positions in BaselNovartis plans to transform its Rhine campus into a center for biological treatments by moving laboratories there by the end of 2028.
    watson.ch

Showing 10 of 30 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novartis with the Signal API

One POST /v1/companies/enrich call with novartis.com returns every signal type for Novartis, each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novartis.com","limit":20}'

Same industry

Companies related to Novartis

Novartis questions

What is the latest news on Novartis?
On Sep 29, 2026, biospace.com reported: 3 steps for taking on Novartis in radiopharma: Curium up first. This page tracks 30 news events for Novartis since May 5, 2026, each with a date and a source link.
What is going on with Novartis?
In the 90 days to Sep 30, 2026, Autobound tracked 22 news events, 3 hiring snapshots, 3 reported layoff rounds, 1 deal, 41 signals for Novartis. The newest story is from Sep 29, 2026 (Revenue), reported by biospace.com.
Is Novartis laying off employees?
bazonline.ch reported on Sep 2, 2026: Novartis cuts 130 jobs in Basel: Biologics production in Kleinbasel to be abandoned. Autobound lists 4 reported layoff rounds for Novartis. Each row states what its source reported, not a confirmed total.
Has Novartis announced any acquisitions?
The latest deal story is from Jul 6, 2026. natlawreview.com reported: Brandon Capital Announces Agreement for Novartis to Acquire Portf. The acquisitions page lists 1 deal with a source for each.
What else does Autobound track for Novartis?
Beyond news and filings, Autobound lists 48+ signals for Novartis from 7 sources: Glassdoor (15+), Website changes (15+), Patents (10), Web traffic (4), Employee growth (2), Reddit (1), LinkedIn (1). See the Novartis signals page for the dated list.
Is Novartis hiring right now?
Yes. As of Sep 29, 2026, Novartis had 337 open roles, and Sales had the most with 28.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →